Corporate financial news and intelligence provider Mergermarket, owned by London-based pan-European private equity firm BC Partners, is said to have sold its Infinata unit for under £20 million, according to the Sunday Times.
Infinata was founded in 1999 with the vision of using data to solve business needs. The company provides web- based solutions which help organizations in the Life Sciences and Financial Services industries turn information into insight. The firm’s first subscription based offering was BioPharm Insight, followed by BioPharm Devices, BioPharm Clinical, High Net Worth Insight and Plan Sponsor Insight.
The move comes amid market speculation of a £1 billion potential exit of Mergermarket, which BC Partners acquired from British international publishing and education company Pearson PLC (LSE: PSON) for roughly £365 million in 2014.
Founded in 2000, Mergermarket subscribers are said to include more than 3,500 advisory firms, investment banks, law firms, hedge funds, private equity firms and corporates. The company has over 1,000 staff in 65 locations around the world, including a 500-strong team of specialist journalists and analysts in 65 locations around the world with headquarters in London, New York and Hong Kong.
Through its web-based products Mergermarket, Dealreporter, Debtwire, BioPharm Insight, PaRR, Wealthmonitor, Remark, Activistmonitor and its acquisition of Infinata, Xtract Research and Inframation Group, the company provides actionable financial intelligence, analysis and data to the advisory, corporate and financial communities.
In 2006 Mergermarket was acquired by the Financial Times Group, a division of Pearson PLC, for £101 million. A year later, Mergermarket acquired Infinata, an information solutions and marketing analytics provider to the global financial service, life science, and high technology industries.
BC Partners, founded in 1986 as Baring Capital Investors Ltd., was spun out of Barings following its collapse in 1995. The firm has grown and evolved into a leader in buyouts, principally investing in larger businesses in the region and selectively in North America through a network of offices in London, Paris, Hamburg and New York. The firm has over €12 billion in assets under management.